His scientific interests lie mostly in Diabetes mellitus, Internal medicine, Type 1 diabetes, Immunology and Endocrinology. His Diabetes mellitus study incorporates themes from Insulin, Pathogenesis and Disease. His Disease study integrates concerns from other disciplines, such as Concordance, Epigenetics, Incidence and Type 2 Diabetes Mellitus.
Paolo Pozzilli has researched Internal medicine in several fields, including Gastroenterology and Placebo. The various areas that Paolo Pozzilli examines in his Type 1 diabetes study include Surgery, Glutamate decarboxylase, Epidemiology and Pediatrics. As a member of one scientific family, Paolo Pozzilli mostly works in the field of Surgery, focusing on Hypoglycemia and, on occasion, Intensive care medicine and Glycated hemoglobin.
Paolo Pozzilli spends much of his time researching Internal medicine, Diabetes mellitus, Endocrinology, Type 1 diabetes and Immunology. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Placebo. His Diabetes mellitus research includes themes of Autoantibody, Insulin, Disease and Intensive care medicine.
His biological study spans a wide range of topics, including Surgery and Nicotinamide. His Type 1 diabetes research is multidisciplinary, incorporating perspectives in Clinical trial, Incidence, Antigen, Pediatrics and Immunotherapy. His Type 2 diabetes research includes themes of Obesity, Insulin resistance and Type 2 Diabetes Mellitus.
Internal medicine, Diabetes mellitus, Type 1 diabetes, Type 2 diabetes and Endocrinology are his primary areas of study. His Internal medicine research incorporates elements of Dulaglutide, Sclerostin, Placebo and Gastroenterology. His Diabetes mellitus study combines topics from a wide range of disciplines, such as Obesity, Autoantibody, Intensive care medicine, Insulin and Disease.
His biological study spans a wide range of topics, including Clinical trial, Incidence, Metabolic control analysis, Diabetic ketoacidosis and Pediatrics. The various areas that Paolo Pozzilli examines in his Type 2 diabetes study include Weight loss, Bioinformatics, Overweight, Quality of life and Glycemic. His Endocrinology research includes elements of Area under the curve and Wnt signaling pathway.
The scientist’s investigation covers issues in Diabetes mellitus, Internal medicine, Type 1 diabetes, Type 2 diabetes and Obesity. His Diabetes mellitus research is multidisciplinary, relying on both Therapeutic approach, Insulin, Pediatrics and Intensive care medicine. Paolo Pozzilli has included themes like Autoantibody, Disease and Coronavirus disease 2019 in his Insulin study.
His study in Internal medicine is interdisciplinary in nature, drawing from both Placebo and Endocrinology. His research in Type 1 diabetes intersects with topics in Absolute risk reduction, Randomized controlled trial, Incidence and Infant formula. Paolo Pozzilli works mostly in the field of Type 2 diabetes, limiting it down to topics relating to Bioinformatics and, in certain cases, Osteoarthritis, Degeneration, Intervertebral disc, Stroke and Metabolic control analysis, as a part of the same area of interest.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry
L Nisticò;R Buzzetti;L E Pritchard;B Van der Auwera.
Human Molecular Genetics (1996)
Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies.
Christopher Cardwell;L.C. Stene;G. Joner;O. Cinek.
C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell Function: Report of an ADA Workshop, 21–22 October 2001
Jerry P. Palmer;G. Alexander Fleming;Carla J. Greenbaum;Kevan C. Herold.
Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers.
Suna Onengut-Gumuscu;Wei-Min Chen;Oliver Burren;Nick J Cooper.
Nature Genetics (2015)
A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes.
Dehuang Guo;Manyu Li;Yan Zhang;Ping Yang.
Nature Genetics (2004)
NOD mouse colonies around the world- recent facts and figures
Paolo Pozzilli;Alberto Signore;Alistair J.K. Williams;Philip E. Beales.
Immunology Today (1993)
Autoimmune Diabetes Not Requiring Insulin at Diagnosis (Latent Autoimmune Diabetes of the Adult): Definition, characterization, and potential prevention
Paolo Pozzilli;Umberto Di Mario.
Diabetes Care (2001)
GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus
Johnny Ludvigsson;David Krisky;Rosaura Casas;Tadej Battelino.
The New England Journal of Medicine (2012)
Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7
Mohammed I. Hawa;Hubert Kolb;Nanette Schloot;Huriya Beyan.
Diabetes Care (2013)
Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes
Ilaria Barchetta;Francesco Angelico;Maria Del Ben;Marco Giorgio Baroni.
BMC Medicine (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: